Measurements on slope parameter mapping based on dual-energy CT enterography for improving Crohn's disease diagnosis and inflammatory activity evaluation

基于双能CT小肠造影的斜率参数映射测量,用于改善克罗恩病诊断和炎症活动度评估

阅读:1

Abstract

To explore the value of slope parameter images (SPI) derived from the dual-phase dual-energy CT enterography (DE-CTE) in the diagnosis and activity evaluation of Crohn's disease (CD). A retrospective analysis of 76 patients with CD and 53 controls who underwent dual-phase DE-CTE between January 2019 and March 2022. CD lesions were divided into non-moderate-to-severe activity (n = 108) and moderate-to-severe activity (n = 59). Virtual monoenergetic images of 40-100 keV and SPI for energy spectrum curves between 40 and 100 keV (SPI(40-100)) were generated. Virtual monoenergetic CT values (HU(40-100keV)) and the slope between 40 and 100 keV measured on SPI(40-100) (SP(40-100)) on intestinal wall and adjacent mesenteric fat for the dual phases were collected. The performances of quantitative parameters in the diagnosis and activity assessment of CD were evaluated. The dual-phase SP(40-100) and HU(40-100) in the affected intestinal wall and adjacent mesenteric fat were higher than those in the control group (P < 0.001). For CD diagnosis, the area under the curve (AUC) of the arterial phase (AP) SP(40-100) of mesenteric fat was the highest (AUC = 0.969, P < 0.05). The dual-phase SP(40-100) and HU(40-100keV) of the intestinal wall and creeping fat in those with moderate-to-severe activity were significantly higher than those with non-moderate-to-severe activity (P < 0.001). For activity assessment, AP-SP(40-100) of creeping fat had the highest AUC among all parameters (AUC = 0.935, P < 0.05). The measurements on SPI(40-100) obtained via dual-phase DE-CTE have high value in CD diagnosis and inflammatory activity evaluation, and the AP SP(40-100) of mesenteric fat has the highest diagnostic efficacy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。